| Title | Chinese Journal of New Drugs |
| Abbreviation | Chin. J. New Drugs |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4) |
| h-index | 12 |
| Overall Rank/Ranking | 25012 |
| SCImago Journal Rank (SJR) | 0.112 |
| Impact Score | 0.14 |
| Publisher | Chinese Journal of New Drugs Co. Ltd. |
| Country | China |
| ISSN | 10033734 |
| Best Quartile | Q4 |
| Coverage History | 2008-2022 |
Chinese Journal of New Drugs is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4). It is published by Chinese Journal of New Drugs Co. Ltd.. The overall rank of Chinese Journal of New Drugs is 25012. According to SCImago Journal Rank (SJR), this journal is ranked 0.112. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 12. The best quartile for this journal is Q4.
The ISSN of Chinese Journal of New Drugs journal is 10033734. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Chinese Journal of New Drugs is cited by a total of 198 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Chinese Journal of New Drugs is 0.14, which is computed in 2023 as per its definition. Chinese Journal of New Drugs IF is increased by a factor of 0.01 and approximate percentage change is 7.69% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Chinese Journal of New Drugs is 0.14. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.14 |
| 2021 | 0.13 |
| 2020 | 0.11 |
| 2019 | 0.06 |
| 2018 | 0.07 |
| 2017 | 0.06 |
| 2016 | 0.08 |
| 2015 | 0.07 |
| 2014 | 0.08 |
Chinese Journal of New Drugs has an h-index of 12. It means 12 articles of this journal have more than 12 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Chinese Journal of New Drugs is 10033734. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Chinese Journal of New Drugs is 25012. According to SCImago Journal Rank (SJR), this journal is ranked 0.112. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.112 |
| 2021 | 0.109 |
| 2020 | 0.111 |
| 2019 | 0.107 |
| 2018 | 0.106 |
| 2017 | 0.108 |
| 2016 | 0.112 |
| 2015 | 0.111 |
| 2014 | 0.111 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 25012 |
| 2021 | 24505 |
| 2020 | 28435 |
| 2019 | 26850 |
| 2018 | 28003 |
| 2017 | 27737 |
| 2016 | 26628 |
| 2015 | 26354 |
| 2014 | 25945 |
Chinese Journal of New Drugs is published by Chinese Journal of New Drugs Co. Ltd.. It's publishing house is located in China. Coverage history of this journal is as following: 2008-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Chinese Journal of New Drugs is Chin. J. New Drugs. This abbreviation ('Chin. J. New Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Chinese Journal of New Drugs latest impact IF is 0.14. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.14 (2022) and 0.06 (2019), respectively, in the last 9 years. Moreover, its average IS is 0.09 in the previous 9 years.
The Chinese Journal of New Drugs has an SJR (SCImago Journal Rank) of 0.112, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.112 in 2022 and the lowest being 0.106 in 2018. Furthermore, the average SJR of the Chinese Journal of New Drugs over the previous 9-year period stands at 0.09.
The latest h-index of the Chinese Journal of New Drugs is 12.
The Chinese Journal of New Drugs is published by the Chinese Journal of New Drugs Co. Ltd., with its country of publication being the China.
The Chinese Journal of New Drugs is currently ranked 25012 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 24505 in 2021 and its lowest position of 28435 in 2020.
The standard ISO4 abbreviation for the Chinese Journal of New Drugs is Chin. J. New Drugs.
Chinese Journal of New Drugs is classified as a journal that the Chinese Journal of New Drugs Co. Ltd. publishes.
The Chinese Journal of New Drugs encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Chinese Journal of New Drugs is assigned the following International Standard Serial Numbers (ISSN): 10033734.
The best quartile for the Chinese Journal of New Drugs is Q4 (2022).
The Chinese Journal of New Drugs coverage history can be summarized as follows: 2008-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 10343 | Vilnius Gediminas Technical University | 45 | 2.81 |
| Journal of Field Archaeology | journal | 5639 | Maney Publishing | 43 | 2.38 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Criminal Justice Review | journal | 8738 | SAGE Publications Inc. | 41 | 1.30 |
| CESifo Economic Studies | journal | 14012 | Oxford University Press | 32 | 1.70 |
| Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
| Journal of Classical Sociology | journal | 13766 | SAGE Publications Ltd | 27 | 0.83 |
| International Journal of Research and Method in Education | journal | 5180 | Taylor and Francis Ltd. | 34 | 2.49 |
| Oral Radiology | journal | 9461 | Springer Japan | 20 | 2.06 |
| Journal of Sociology | journal | 6009 | SAGE Publications Ltd | 58 | 3.21 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.14 |
| 2021 | 0.13 |
| 2020 | 0.11 |
| 2019 | 0.06 |
| 2018 | 0.07 |
| 2017 | 0.06 |
| 2016 | 0.08 |
| 2015 | 0.07 |
| 2014 | 0.08 |
